Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.06
-0.02-0.22%
At close: -
$9.06
0.000.00%
After Hours: Jul 18, 4:01 PM EDT
Comments
Loading...
NeuroPace Analyst Ratings and Price Targets | NASDAQ:NPCE | Benzinga
NeuroPace Inc has a consensus price target of $16 based on the ratings of 10 analysts. The high is $22 issued by Leerink Partners on January 30, 2024. The low is $8 issued by Morgan Stanley on July 15, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., JP Morgan, and Cantor Fitzgerald on May 28, 2025, May 14, 2025, and May 14, 2025, respectively. With an average price target of $17 between HC Wainwright & Co., JP Morgan, and Cantor Fitzgerald, there's an implied 87.64% upside for NeuroPace Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JP Morgan
Cantor Fitzgerald
Wells Fargo
UBS
1calculated from analyst ratings
Analyst Ratings for NeuroPace
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
05/28/2025 | 98.68% | HC Wainwright & Co. | → $18 | Initiates | → Buy | |||
05/14/2025 | 76.6% | JP Morgan | $14 → $16 | Maintains | Overweight | |||
05/14/2025 | 87.64% | Cantor Fitzgerald | $17 → $17 | Reiterates | Overweight → Overweight | |||
03/05/2025 | 120.75% | Cantor Fitzgerald | $19 → $20 | Maintains | Overweight | |||
01/30/2025 | 87.64% | Wells Fargo | $13 → $17 | Maintains | Overweight | |||
01/21/2025 | 87.64% | UBS | → $17 | Initiates | → Buy | |||
12/17/2024 | 54.53% | JP Morgan | $9 → $14 | Maintains | Overweight | |||
11/13/2024 | 43.49% | Wells Fargo | $15 → $13 | Maintains | Overweight | |||
08/14/2024 | 98.68% | Cantor Fitzgerald | $18 → $18 | Reiterates | Overweight → Overweight | |||
08/14/2024 | 65.56% | Wells Fargo | $20 → $15 | Maintains | Overweight | |||
07/15/2024 | -11.7% | Morgan Stanley | $9.5 → $8 | Maintains | Equal-Weight | |||
05/09/2024 | 98.68% | Cantor Fitzgerald | $18 → $18 | Reiterates | Overweight → Overweight | |||
03/14/2024 | 120.75% | Wells Fargo | $16 → $20 | Upgrade | Equal-Weight → Overweight | |||
03/12/2024 | 87.64% | JP Morgan | $9 → $17 | Maintains | Overweight | |||
03/06/2024 | 98.68% | Cantor Fitzgerald | $16 → $18 | Maintains | Overweight | |||
03/06/2024 | 43.49% | Morgan Stanley | $9 → $13 | Maintains | Equal-Weight | |||
02/22/2024 | 76.6% | Wells Fargo | $9 → $16 | Maintains | Equal-Weight | |||
01/30/2024 | 142.83% | Leerink Partners | → $22 | Initiates | → Outperform | |||
12/27/2023 | 32.45% | Lake Street | $12 → $12 | Reiterates | Buy → Buy | |||
12/04/2023 | -0.66% | Morgan Stanley | $8 → $9 | Maintains | Equal-Weight | |||
11/14/2023 | -11.7% | Morgan Stanley | $6 → $8 | Maintains | Equal-Weight | |||
11/10/2023 | 21.41% | Cantor Fitzgerald | → $11 | Initiates | → Overweight | |||
11/07/2023 | -0.66% | JP Morgan | $6 → $9 | Maintains | Overweight | |||
10/04/2023 | -0.66% | Wells Fargo | $6 → $9 | Maintains | Equal-Weight | |||
08/24/2023 | -33.77% | Morgan Stanley | $5 → $6 | Upgrade | Underweight → Equal-Weight | |||
05/05/2023 | -44.81% | Morgan Stanley | $4.5 → $5 | Maintains | Underweight | |||
03/03/2023 | -50.33% | Morgan Stanley | $2.5 → $4.5 | Maintains | Underweight | |||
02/22/2023 | 10.38% | Lake Street | → $10 | Initiates | → Buy | |||
01/06/2023 | -72.41% | Morgan Stanley | $3.5 → $2.5 | Maintains | Underweight | |||
10/11/2022 | -61.37% | Morgan Stanley | $5.5 → $3.5 | Maintains | Underweight |
FAQ
What is the target price for NeuroPace (NPCE) stock?
The latest price target for NeuroPace (NASDAQ:NPCE) was reported by HC Wainwright & Co. on May 28, 2025. The analyst firm set a price target for $18.00 expecting NPCE to rise to within 12 months (a possible 98.68% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NeuroPace (NPCE)?
The latest analyst rating for NeuroPace (NASDAQ:NPCE) was provided by HC Wainwright & Co., and NeuroPace initiated their buy rating.
When was the last upgrade for NeuroPace (NPCE)?
The last upgrade for NeuroPace Inc happened on March 14, 2024 when Wells Fargo raised their price target to $20. Wells Fargo previously had an equal-weight for NeuroPace Inc.
When was the last downgrade for NeuroPace (NPCE)?
There is no last downgrade for NeuroPace.
When is the next analyst rating going to be posted or updated for NeuroPace (NPCE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeuroPace, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeuroPace was filed on May 28, 2025 so you should expect the next rating to be made available sometime around May 28, 2026.
Is the Analyst Rating NeuroPace (NPCE) correct?
While ratings are subjective and will change, the latest NeuroPace (NPCE) rating was a initiated with a price target of $0.00 to $18.00. The current price NeuroPace (NPCE) is trading at is $9.06, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
